Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
The Medical Clinics of North America
|
October 24, 2021
Evolving Concepts of Type 2 Diabetes Management
Layla A Abushamat, Jane E B Reusch
Current Cardiology Reports
|
July 20, 2024
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?
Jennifer M Kaplan, Adnin Zaman, Layla A Abushamat
Journal of Neuropathology and Experimental Neurology
|
June 25, 2019
Very Unusual Sellar/Suprasellar Region Masses: A Review
Layla A Abushamat, Janice M Kerr, M Beatriz S Lopes, et al.
Current Atherosclerosis Reports
|
August 4, 2021
Obesity Management in Cardiometabolic Disease: State of the Art
Sean J Iwamoto, Layla A Abushamat, Adnin Zaman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 17, 2024
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
Layla A Abushamat, Pir Ahmad Shah, Robert H Eckel, et al.
The American Journal of Cardiology
|
March 20, 2022
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs)
Mahmoud Al Rifai, Elizabeth M Vaughan, Layla A Abushamat, et al.
American Journal of Preventive Cardiology
|
September 3, 2024
Bempedoic Acid in Secondary Prevention
Idine Mousavi, Vijay Nambi, Layla A Abushamat, et al.
Journal of Clinical Lipidology
|
February 17, 2026
The impact of genetic testing on physician practice in specialized cardiovascular clinics
Arsalan Hamid, Tyler Sewell, Sucheta Bhatt, et al.
Journal of Clinical Lipidology
|
March 25, 2026
C-reactive protein-triglyceride-glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome
Sahil Ghay, Mohamad K Elajami, Baneet Kaur, et al.
The American Journal of Medicine
|
October 25, 2023
Social Vulnerability and Cardiovascular-Related Mortality Among Older Adults in the United States
Abdul Mannan Khan Minhas, Ofer Kobo, Mamas A Mamas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
The Medical Clinics of North America
|
October 24, 2021
Evolving Concepts of Type 2 Diabetes Management
Layla A Abushamat, Jane E B Reusch
Current Cardiology Reports
|
July 20, 2024
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?
Jennifer M Kaplan, Adnin Zaman, Layla A Abushamat
Journal of Neuropathology and Experimental Neurology
|
June 25, 2019
Very Unusual Sellar/Suprasellar Region Masses: A Review
Layla A Abushamat, Janice M Kerr, M Beatriz S Lopes, et al.
Current Atherosclerosis Reports
|
August 4, 2021
Obesity Management in Cardiometabolic Disease: State of the Art
Sean J Iwamoto, Layla A Abushamat, Adnin Zaman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 17, 2024
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
Layla A Abushamat, Pir Ahmad Shah, Robert H Eckel, et al.
The American Journal of Cardiology
|
March 20, 2022
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs)
Mahmoud Al Rifai, Elizabeth M Vaughan, Layla A Abushamat, et al.
American Journal of Preventive Cardiology
|
September 3, 2024
Bempedoic Acid in Secondary Prevention
Idine Mousavi, Vijay Nambi, Layla A Abushamat, et al.
Journal of Clinical Lipidology
|
February 17, 2026
The impact of genetic testing on physician practice in specialized cardiovascular clinics
Arsalan Hamid, Tyler Sewell, Sucheta Bhatt, et al.
Journal of Clinical Lipidology
|
March 25, 2026
C-reactive protein-triglyceride-glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome
Sahil Ghay, Mohamad K Elajami, Baneet Kaur, et al.
The American Journal of Medicine
|
October 25, 2023
Social Vulnerability and Cardiovascular-Related Mortality Among Older Adults in the United States
Abdul Mannan Khan Minhas, Ofer Kobo, Mamas A Mamas, et al.
Page
of 3